ProCE Banner Activity

患者对 HIV 治疗和预防的需求:PrEP 持久性

Multimedia

在这一视频圆桌会议中,从患者倡权人和专家处了解到全球范围内阻碍 PrEP 持久性的主要障碍,以及医疗保健专业人员可以做些什么来克服它们。

Released: December 21, 2022

Expiration: December 20, 2023

No longer available for credit.

Share

Faculty

Tony Christon-Walker

Tony Christon-Walker

Community Advocate and Activist
Birmingham, Alabama

Jill Blumenthal

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Chelsea Gulden

Chelsea Gulden, MSW

Patient

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Program Director Disclosure

Program Director

Tony Christon-Walker,

Community Advocate and Activist
Birmingham, Alabama

Tony Christon-Walker:咨询/导师/发言人:Gilead Sciences, ViiV.

Faculty Disclosure

Primary Author

Jill Blumenthal, MD, MAS

Associate Professor of Medicine
Infectious Diseases and Global Public Health
University of California, San Diego
San Diego, California

Jill Blumenthal,医学博士,MAS:研究机构:Gilead Sciences。

Chelsea Gulden, MSW

Patient

Chelsea Gulden,社会工作硕士,没有要披露的相关财务关系。